GENB
Generate Biomedicines, Inc.
13.49
-0.29 (-2.10%)
52w low 11.00
22.67 high
21.3% of range
Financial Analysis
| Ratio | Mar 25 | Jun 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|
| Profitability | |||||
| Operating Margin | -546.1% | -593.8% | -887.5% | -1,134.2% | |
| EBITDA Margin | -459.0% | -523.9% | -806.1% | -1,010.8% | |
| Net Margin | -472.7% | -517.6% | -850.6% | -1,065.2% | |
| FCF Margin | -611.6% | -482.8% | -1,165.1% | -932.5% | |
| Returns | |||||
| Return on Equity | -- | -- | -11.9% | -14.7% | |
| Return on Assets | -- | -- | -9.8% | -12.0% | |
| Return on Inv Capital | -- | -- | -12.0% | -14.7% | |
| Liquidity | |||||
| Current Ratio | -- | -- | 9.17x | 8.30x | |
| Quick Ratio | -- | -- | 9.17x | 8.30x | |
| Cash Ratio | -- | -- | 2.75x | 2.39x | |
| Leverage | |||||
| Debt / Equity | -- | -- | 0.13x | 0.14x | |
| Interest Coverage | -119.27x | -183.68x | -337.93x | -432.56x | |
| Equity Multiplier | -- | -- | 1.22x | 1.23x | |
| Efficiency | |||||
| Asset Turnover | -- | -- | 0.01x | 0.01x | |
| Effective Tax Rate | -0.1% | -0.1% | -0.0% | -0.1% | |
| Op CF / Net Income | 1.28x | 0.93x | 1.31x | 0.86x | |
| Investment | |||||
| Capex / Revenue | 8.5% | 1.5% | 52.3% | 14.8% | |
| R&D / Revenue | 531.0% | 589.7% | 800.3% | 1,018.8% | |
| SG&A / Revenue | 115.1% | 104.1% | 187.2% | 215.4% | |
Revenue CAGR
-10.5%
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
-12.6%